JP2023175688A5 - - Google Patents

Download PDF

Info

Publication number
JP2023175688A5
JP2023175688A5 JP2023132463A JP2023132463A JP2023175688A5 JP 2023175688 A5 JP2023175688 A5 JP 2023175688A5 JP 2023132463 A JP2023132463 A JP 2023132463A JP 2023132463 A JP2023132463 A JP 2023132463A JP 2023175688 A5 JP2023175688 A5 JP 2023175688A5
Authority
JP
Japan
Prior art keywords
patient
gdc
labc
mbc
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023132463A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023175688A (ja
Filing date
Publication date
Priority claimed from JP2022515505A external-priority patent/JP2023500558A/ja
Application filed filed Critical
Publication of JP2023175688A publication Critical patent/JP2023175688A/ja
Publication of JP2023175688A5 publication Critical patent/JP2023175688A5/ja
Pending legal-status Critical Current

Links

JP2023132463A 2020-05-12 2023-08-16 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療 Pending JP2023175688A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063023501P 2020-05-12 2020-05-12
US63/023,501 2020-05-12
JP2022515505A JP2023500558A (ja) 2020-05-12 2021-05-10 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療
PCT/US2021/031491 WO2021231250A1 (en) 2020-05-12 2021-05-10 Treatment of breast cancer using combination therapies comprising gdc-9545 and a cdk4/6 inhibitor

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022515505A Division JP2023500558A (ja) 2020-05-12 2021-05-10 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療

Publications (2)

Publication Number Publication Date
JP2023175688A JP2023175688A (ja) 2023-12-12
JP2023175688A5 true JP2023175688A5 (https=) 2025-12-16

Family

ID=76250442

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2022515505A Withdrawn JP2023500558A (ja) 2020-05-12 2021-05-10 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療
JP2023132463A Pending JP2023175688A (ja) 2020-05-12 2023-08-16 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療
JP2024045217A Pending JP2024102045A (ja) 2020-05-12 2024-03-21 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022515505A Withdrawn JP2023500558A (ja) 2020-05-12 2021-05-10 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024045217A Pending JP2024102045A (ja) 2020-05-12 2024-03-21 Gdc-9545及びcdk4/6阻害剤を含む併用療法を使用した乳がん治療

Country Status (11)

Country Link
US (2) US11918561B2 (https=)
EP (1) EP4149476A1 (https=)
JP (3) JP2023500558A (https=)
KR (1) KR20230009390A (https=)
CN (2) CN115551513B (https=)
AU (1) AU2021272100B2 (https=)
CA (1) CA3182018A1 (https=)
IL (1) IL298071A (https=)
MX (1) MX2022014133A (https=)
TW (1) TWI800827B (https=)
WO (1) WO2021231250A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2023009374A (es) * 2021-02-16 2023-08-16 Genentech Inc Tratamiento de cancer de mama mediante el uso de tratamientos conjuntos que comprenden gdc-9545 y abemaciclib o ribociclib.
IL315153A (en) * 2022-03-14 2024-10-01 Genentech Inc Combined treatments for breast cancer
CN121337802B (zh) * 2025-10-23 2026-04-14 安徽益普克医药科技发展有限公司 一种雌激素降解剂衍生物及其制备方法与用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102529049B1 (ko) * 2013-08-14 2023-05-08 노파르티스 아게 암의 치료를 위한 조합 요법
KR102358935B1 (ko) * 2014-02-12 2022-02-04 가부시키가이샤 한도오따이 에네루기 켄큐쇼 전자 기기
KR102785474B1 (ko) * 2014-12-18 2025-03-26 에프. 호프만-라 로슈 아게 테트라하이드로-피리도[3,4-b]인돌 에스트로겐 수용체 조절제 및 이의 용도
JP7019422B2 (ja) * 2015-04-29 2022-02-15 ラジウス ファーマシューティカルズ,インコーポレイテッド 癌を治療するための方法
KR20180119570A (ko) 2016-03-15 2018-11-02 메리맥 파마슈티컬즈, 인크. 항-ErbB3 항체를 포함하는 병용 요법을 이용한 ER+, HER2-, HRG+ 유방암의 치료
LT3810283T (lt) * 2018-06-21 2023-08-25 F. Hoffmann-La Roche Ag 3-((1r,3r)-1-(2,6-difluor-4-((1-(3-fluorpropil)azetidin-3- il)amino) fenil)-3-metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)- 2,2- difluorpropan-1-olio tartrato druskos kietosios formos, jų paruošimo procesas ir jų naudojimo būdai vėžiui gydyti
CA3109090A1 (en) 2018-08-17 2020-02-20 F. Hoffmann-La Roche Ag Diagnostic and therapeutic methods for the treatment of breast cancer
JP7826068B2 (ja) * 2022-03-11 2026-03-09 本田技研工業株式会社 パワーユニット、及びパワーユニットを搭載した作業機

Similar Documents

Publication Publication Date Title
JP2023175688A5 (https=)
JP2024102045A5 (https=)
CN1103589C (zh) 调节人体性反应的方法
US5470883A (en) Method of treating peripheral vasoconstriction with tamoxifen citrate
JP2019529581A5 (https=)
TW202333675A (zh) 用於治療癌症之組合療法之用途
JP2019529574A5 (https=)
TW202304424A (zh) 包含依維莫司和安森司群的組合
JP2019508476A5 (https=)
JP2018123168A (ja) 癌療法における使用のためのトランス−クロミフェン
JP6743001B2 (ja) シス−クロミフェンを用いたアンドロゲン除去療法によって生じるホットフラッシュ及び骨量減少の治療
CN1407890A (zh) 牛皮癣的治疗
CN1929835A (zh) 芳香酶抑制剂治疗-相关的骨质疏松症的治疗
JP2022058873A5 (https=)
US11833119B2 (en) Combination therapies for the treatment of hepatocellular carcinoma
JPWO2021030248A5 (https=)
CN101010074A (zh) 选择性雌激素受体调节剂在制备用于治疗或预防雄激素缺乏的药物制剂中的用途
KR20150132888A (ko) 파록세틴으로 체온 조절 기능 이상을 치료하는 방법
TW201244732A (en) Ezatiostat for treating multiple myeloma
US20040068000A1 (en) Compression coated tablets
JPWO2020037152A5 (https=)
JPWO2023100070A5 (https=)
EP4681723A1 (en) Pharmaceutical composition for treating triple-negative breast cancer
JP2009526013A (ja) イバンドロネートの新規投与計画
JPWO2021026454A5 (https=)